We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Promethean | LSE:PTH | London | Ordinary Share | GB00B08H5G38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.125 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:0111N
PPL Therapeutics PLC
01 July 2003
PPL Therapeutics plc ("the Company")
DISCLOSURE OF INTEREST
The Company has received notification that, following a disposal of 11,230,500
shares on behalf of a commingled fund, RAB Capital Limited no longer has a
notifiable interest in the Ordinary shares of 1p each in the Company.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUAAUROWRBRAR
1 Year Promethean Chart |
1 Month Promethean Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
